Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Hangzhou 101 Beijing 3 Jiaxing 3 Hanzhou 2 Chongqing 2
Narrow the registerReset
Recruitment status
Phase
Site location
Hangzhou101 Beijing3 Jiaxing3 Hanzhou2 Chongqing2
All 36 locations
Target enrolment
to

Trials with a site in Hangzhou

101 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation
NCT07637721Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Zhejiang University
Not applicable
410
Tianjin, Hangzhou
2026-11-12
Not yet open
Zhejiang University
Not applicable
166
Kaifeng, Nanchang, Aksu, Hangzhou, Jiaxing, Taizhou
2026-10-15
Recruiting
Zhejiang University
Observational
1,020
Hangzhou
2026-09-01
Not yet open
Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia
NCT07766668Deglutition Disorders, Ischemic Stroke
Zhejiang University
Not applicable
112
Hangzhou
2026-09-01
Not yet open
Zhejiang University
Not applicable
3,300
Hangzhou
2026-09
Not yet open
High-Flow Nasal Cannula Oxygenation During Sedated Gastrointestinal Endoscopy in Patients With Chronic Obstructive Pulmonary Disease
NCT07791979Hypoxemia, Gastric Cancer (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Esophageal Cancer
Zhejiang University
Not applicable
90
Hangzhou
2026-08-29
Not yet open
Zhejiang University
Phase 1/2
80
Hangzhou
2026-08-15
Not yet open
Zhejiang University
Phase 2
240
Hangzhou
2026-08-10
Not yet open
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation Surgery
NCT07644104Thoracic Surgery With One-lung Ventilation, Lung Isolation, Bronchial Blockage, Anesthesia
Zhejiang University
Not applicable
652
Hangzhou
2026-08-01
Active, closed
Zhejiang University
Not applicable
2,500
Hangzhou
2026-07-17
Recruiting
Zhejiang University
Phase 2
25
Hangzhou
2026-06-30
Recruiting
Zhejiang University
Phase 2
40
Hangzhou
2026-04-30
By invitation
Zhejiang University
Early Phase 1
18
Hangzhou
2026-04-12
Not yet open
Zhejiang University
Not applicable
430
Hangzhou, Wenzhou, Chongqing
2026-04-01
Not yet open
Zhejiang University
Early Phase 1
27
Hangzhou
2026-03-30
Not yet open
Zhejiang University
Not applicable
220
Hangzhou
2026-03-20
Not yet open
Video Double-Lumen Tube for Secondary Pulmonary Resection
NCT07467005Lung Cancer, Pulmonary Nodule
Zhejiang University
Not applicable
500
Hangzhou, Yiwu
2026-03-16
Active, closed
Zhejiang University
Not applicable
100,000
Hangzhou
2026-03-07
Recruiting
Zhejiang University
Early Phase 1
16
Hangzhou
2026-02-28
Recruiting
Zhejiang University
Phase 2
40
Hangzhou
2026-02-15
Not yet open
IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
NCT07415525Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma
DrugIBI343
Zhejiang University
Phase 2
40
Hangzhou
2026-02-01
Recruiting
TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
NCT07480785Uterine Fibroids (Leiomyoma), Ovarian Tumors, Gallstones
Zhejiang University
Not applicable
780
Hangzhou
2026-01-16
Recruiting
Zhejiang University
Phase 1
30
Hangzhou
2026-01-02
Recruiting
Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP
NCT07607990Prostate Cancer (Post Prostatectomy), Perioperative Anesthetic, Catheter-related Bladder Discomfort (CRBD)
Zhejiang University
Not applicable
130
Hangzhou
2026-01-01
Recruiting
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
NCT07307560Hypoxia, Esophageal Cancer, Gastric Cancer (Diagnosis), Obstructive Sleep Apnea (OSA)
Zhejiang University
Not applicable
600
Hangzhou, Jiaxing, Quzhou
2025-12-21
Recruiting
Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine
NCT07263295Diaphragmatic Function, Metacarpal Fracture, Radius Fracture, Peripheral Nerve Neurolysis
Zhejiang University
Not applicable
120
Hangzhou
2025-12-05
Recruiting
Zhejiang University
Phase 2
50
Hangzhou
2025-11-30
Recruiting
Zhejiang University
Phase 1
20
Hangzhou
2025-11-30
Recruiting
Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NCT07252102Liver Cirrhosis, Polyps of Colon, Gastrointestinal Dysfunction
Zhejiang University
Not applicable
450
Shenzhen, Hangzhou
2025-11-20
Recruiting
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
NCT07359586Gastric Cancer, Hepatic Carcinoma, Pulmonary Carcinoma, Pancreatic Carcinoma
Zhejiang University
Observational
1,200
Hangzhou
2025-11-01
Recruiting
Zhejiang University
Not applicable
410
Beijing, Jinjiang, Hangzhou, Lishui, Taizhou
2025-10-24
Recruiting
Zhejiang University
Early Phase 1
50
Hangzhou
2025-09-05
Recruiting
Zhejiang University
Observational
5,000
Hangzhou, Jiaxing, Lishui
2025-08-03
Recruiting
Zhejiang University
Phase 1/2
20
Hangzhou
2025-08-01
Recruiting
Zhejiang University
Not applicable
66
Hangzhou
2025-07-30
Recruiting
Zhejiang University
Not applicable
12
Hangzhou
2025-06-28
Recruiting
Zhejiang University
Phase 4
218
Hangzhou
2025-06-25
Recruiting
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
NCT07051980Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Zhejiang University
Phase 2
50
Hangzhou
2025-06-12
Recruiting
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
NCT07012772Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Zhejiang University
Phase 2
50
Hangzhou
2025-06-12
Recruiting
Zhejiang University
Phase 1
12
Hangzhou
2025-06-10
Active, closed
Zhejiang University
Phase 2
24
Hangzhou
2025-06-01
Recruiting
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
NCT06912152B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University
Phase 1
12
Hangzhou
2025-05-12
Not yet open
Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
NCT06922916COPD, Interstitial Pneumonia, Bronchiectasis, Respiratory Failure
Zhejiang University
Observational
250
Hangzhou
2025-04-22
Recruiting
Zhejiang University
Phase 2
64
Hangzhou
2025-04-18
Recruiting
Zhejiang University
Not applicable
580
Hangzhou
2025-04-11
Recruiting
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-09
Recruiting
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-09
Recruiting
Zhejiang University
Early Phase 1
18
Hangzhou
2025-04-08
Not yet open
Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.
NCT06888648Pancreatic Cancer Metastatic, Pancreatic Cancer Non-resectable
Zhejiang University
Phase 1/2
30
Hangzhou
2025-04-01
Not yet open
Zhejiang University
Phase 1/2
60
Hangzhou
2025-04-01
Not yet open
Zhejiang University
Early Phase 1
18
Hangzhou
2025-04
Recruiting
Zhejiang University
Phase 2
133
Hangzhou
2025-03-25
Not yet open
Zhejiang University
Phase 2
20
Hangzhou
2025-03-01
Recruiting
Zhejiang University
Early Phase 1
20
Hangzhou
2025-01-31
Recruiting
Zhejiang University
Early Phase 1
15
Hangzhou
2025-01-31
Recruiting
Zhejiang University
Early Phase 1
20
Hangzhou
2025-01-30
Not yet open
Zhejiang University
Phase 2
43
Hangzhou
2025-01-15
Not yet open
Zhejiang University
Early Phase 1
6
Hangzhou
2025-01-10
Recruiting
Zhejiang University
Early Phase 1
27
Hangzhou
2025-01-10
Recruiting
Zhejiang University
Phase 1
12
Hangzhou
2025-01-10
Not yet open
Zhejiang University
Observational
20
Hangzhou
2024-12-28
Recruiting
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
NCT06937567Biliary Tract Cancer, Colorectal Carcinoma, Gastric Cancer, Metastatic, Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
Zhejiang University
Early Phase 1
36
Hangzhou
2024-12-26
Recruiting
Zhejiang University
Early Phase 1
36
Hangzhou
2024-12-24
Recruiting
Zhejiang University
Early Phase 1
36
Hangzhou
2024-12-01
Recruiting
Zhejiang University
Phase 1
58
Beijing, Xi’an, Hangzhou
2024-10-23
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
NCT06633354T-Acute Lymphoblastic Leukemia
Zhejiang University
Early Phase 1
30
Hangzhou
2024-10-20
Recruiting
Zhejiang University
Early Phase 1
30
Hangzhou
2024-10-20
Not yet open
Zhejiang University
Not applicable
200,000
Hangzhou
2024-08-15
Recruiting
Zhejiang University
Not applicable
5
Hangzhou
2024-08-10
Not yet open
Zhejiang University
Observational
3,000
Hangzhou
2024-08-01
Recruiting
Zhejiang University
Phase 1
15
Hangzhou
2024-07-01
Recruiting
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
NCT06346912Acute Lymphoblastic Leukemia,B-Cell, Non-hodgkin Lymphoma,B Cell
Zhejiang University
Early Phase 1
20
Hangzhou
2024-05-30
Recruiting
Zhejiang University
Early Phase 1
45
Hangzhou
2024-04-15
Recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
NCT06220617Colorectal Cancer, Adenomatous Polyps, Adenoma, Advanced Adenoma
Zhejiang University
Observational
3,600
Hangzhou, Guangzhou, Kunming, Nanjing, Xi'an, Zhengzhou
2024-01-11
Recruiting
Zhejiang University
Early Phase 1
7
Hangzhou
2023-11-02
Recruiting
A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
NCT05886114Cognitive Impairment, Alzheimer Disease, Vascular Cognitive Impairment, Dement
Zhejiang University
Not applicable
1,200
Hangzhou
2023-05-28
Recruiting
Zhejiang University
Phase 2
49
Hangzhou
2023-05-15
Recruiting
Zhejiang University
Phase 1/2
30
Hangzhou
2023-04-30
Recruiting
Zhejiang University
Phase 3
190
Hangzhou
2023-03-01
Recruiting
Zhejiang University
Not applicable
30
Hangzhou
2023-03-01
Not yet open
Zhejiang University
Phase 3
38
Shanghai, Hangzhou, Ningbo
2023-03
Recruiting
Zhejiang University
Phase 2
50
Hangzhou
2023-02-22
Recruiting
Zhejiang University
Observational
108
Hangzhou
2023-02-07
Recruiting
Zhejiang University
Observational
5,000
Hangzhou
2022-07-01
Recruiting
APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
NCT04657861Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Zhejiang University
Early Phase 1
36
Hangzhou
2022-05-03
Recruiting
Zhejiang University
Phase 1
72
Hangzhou, Zhengzhou
2022-02-21
Recruiting
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
NCT04662294Acute Myeloid Leukemia, Non-hodgkin's Lymphoma, Multiple Myeloma
Zhejiang University
Early Phase 1
108
Hangzhou
2021-11-18
Active, closed
Zhejiang University
Phase 1
21
Hangzhou
2021-03-10
Not yet open
Zhejiang University
Early Phase 1
144
Hangzhou
2021-01-15
Not yet open
Zhejiang University
Early Phase 1
36
Hangzhou
2021-01-15
Not yet open
Zhejiang University
Early Phase 1
36
Hangzhou
2021-01-01
Not yet open
A Study of Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
NCT04670055Relapse Multiple Myeloma, Refractory Multiple Myeloma
Zhejiang University
Early Phase 1
50
Hangzhou
2021-01-01
Not yet open
Zhejiang University
Early Phase 1
50
Hangzhou
2020-12-31
Recruiting
Zhejiang University
Phase 2
40
Hangzhou
2020-12-03
Recruiting
Zhejiang University
Not applicable
1,000
Hangzhou
2020-12-01
Not yet open
CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
NCT04609241Relapsed and/or Refractory Acute Lymphoblastic Leukemia, Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma
Zhejiang University
Early Phase 1
72
Hangzhou
2020-11-15
Not yet open
Zhejiang University
Early Phase 1
36
Hangzhou
2020-11-15
Recruiting
The Jiaxing Birth Cohort in China
NCT03217656Childhood Obesity, Anemia, Pregnancy Complications, Pregnancy; Hypertension
Zhejiang University
Observational
500,000
Hangzhou
1999-01
Rows per page Showing 1–101 of 101
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 101 of those studies with a site in Hangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Hangzhou?

64 of the 101 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 31 have not yet opened recruitment, 5 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hangzhou), 101 studies
PhaseStudiesRecruitingShare
Early Phase 1281727.7%
Not applicable251324.8%
Phase 2171216.8%
Observational11810.9%
Phase 11089.9%
Phase 1/2746.9%
Phase 3212%
Phase 4111%

Most active sponsors

Lead sponsors with the most studies (Hangzhou)
Lead sponsorStudiesRecruiting
Zhejiang University10164
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.